Lixte Biotechnology Holdings, Inc. - Common Stock (LIXT)

Lixte Biotech Holdings is a biotechnology company focused on the discovery and development of novel therapeutics for the treatment of cancer and other life-threatening diseases

The company specializes in cell death pathways, aiming to identify and advance drug candidates that can effectively target and disrupt these pathways to induce cancer cell death. By leveraging its proprietary technology and research, Lixte seeks to bring innovative solutions to the market, contributing to the advancement of cancer treatment and improving patient outcomes.